Evaluation of Rapid Virologic Response Among HCV Patients Treated With PegIntron and Rebetol in Brazil (Study P05427)
Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
The objective of the study is to evaluate, in each group, the number of participants who
achieve rapid virological response (RVR) after 4 weeks treatment with PegIntron and Rebetol.
The study will also assess whether RVR is a reliable predictor of sustained virologic
response (defined as undetectable viral load at 24 weeks post-treatment).